OrthoPediatrics Corp.
KIDS · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | -0.14 | 0.51 | 0.40 | -0.08 |
| FCF Yield | -0.79% | -2.77% | -1.47% | -0.69% |
| EV / EBITDA | -97.42 | -712.19 | -142.67 | -438.32 |
| Quality | ||||
| ROIC | -1.05% | -1.66% | -2.58% | -1.90% |
| Gross Margin | 73.92% | 72.07% | 73.00% | 67.53% |
| Cash Conversion Ratio | 0.05 | 1.47 | 0.39 | 0.25 |
| Growth | ||||
| Revenue 3-Year CAGR | 16.97% | 17.21% | 17.65% | 18.74% |
| Free Cash Flow Growth | 75.41% | -65.90% | -125.05% | 68.05% |
| Safety | ||||
| Net Debt / EBITDA | -6.57 | -67.63 | -9.27 | -28.30 |
| Interest Coverage | -2.67 | -6.89 | -9.75 | -6.49 |
| Efficiency | ||||
| Inventory Turnover | 0.12 | 0.14 | 0.12 | 0.15 |
| Cash Conversion Cycle | 760.61 | 673.07 | 746.95 | 641.25 |